Why was Motival discontinued? Understanding the reasons for its withdrawal
•
4 min read
In 2008, the pharmaceutical company Bristol-Myers Squibb announced that Motival (fluphenazine hydrochloride 500µg), a medication used for mixed anxiety and depression, would be discontinued globally for commercial reasons. This decision ended the availability of a fixed-dose combination drug, highlighting shifts in pharmaceutical treatment paradigms.
